2021•Unpublished venueRequires access
Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A prospective 24-week study
Praveen Rikhari, Ashutosh Kumar
Open publisher page 0 citations
Abstract
Metabolic derangements are common with antipsychotic medications leading to increased morbidity and mortality due to diabetes mellitus, stroke, and cardiovascular events in schizophrenia spectrum and other psychotic disorders as these require long term treatment.